2 692

Cited 52 times in

Lymphovascular invasion and pT stage are prognostic factors in patients treated with radical nephroureterectomy for localized upper urinary tract transitional cell carcinoma

DC Field Value Language
dc.contributor.author김동석-
dc.contributor.author이영훈-
dc.contributor.author정병하-
dc.contributor.author조강수-
dc.contributor.author조남훈-
dc.contributor.author홍성준-
dc.date.accessioned2015-04-23T16:30:07Z-
dc.date.available2015-04-23T16:30:07Z-
dc.date.issued2010-
dc.identifier.issn0090-4295-
dc.identifier.urihttps://ir.ymlib.yonsei.ac.kr/handle/22282913/100699-
dc.description.abstractOBJECTIVES: To investigate the prognostic significance of lymphovascular invasion (LVI) in patients with localized upper urinary tract transitional cell carcinoma (UUT-TCC) after radical nephroureterectomy. METHODS: The clinical records of 271 patients with UUT-TCC who underwent radical nephroureterectomy between 1986 and 2006 were reviewed. Patients with pT4 stage, lymph node involvement, or distant metastasis were excluded. A total of 238 patients with pTa-3N0M0 were eligible. The prognostic significance of various clinicopathologic factors was analyzed using univariate and multivariate analysis. The mean age was 64.1 years (range, 25-91 years) and the median follow-up duration was 53.4 months (range, 3-240 months). RESULTS: LVI was present in 31 patients (13%). LVI was related to higher pT stage, high tumor grade, sessile architecture, and squamous differentiation. On univariate analysis, tumor architecture, squamous differentiation, LVI, tumor grade, and pT stage influenced disease-specific survival. On multivariate analysis, LVI (hazards ratio [HR], 2.33; P = .014) and pT stage (HR, 2.07; P = .021) showed significantly different rates of disease-specific survival. Patients were classified according to pT stage and LVI. The high-risk group (pT3 and LVI+) showed significantly worse disease-specific survival than the low- (pT < or = 2 and LVI-) or intermediate-risk groups (pT3 and LVI-, pT < or = 2 and LVI+) (P <.001 and P = .032, respectively). CONCLUSIONS: LVI and pT stage are significant prognostic factors for recurrence-free and cancer-specific survivals in patients with localized UUT-TCC. LVI and pT stage would be helpful for selecting patients who are appropriate for postoperative adjuvant chemotherapy-
dc.description.statementOfResponsibilityopen-
dc.format.extent328~332-
dc.relation.isPartOfUROLOGY-
dc.rightsCC BY-NC-ND 2.0 KR-
dc.rights.urihttps://creativecommons.org/licenses/by-nc-nd/2.0/kr/-
dc.subject.MESHAdult-
dc.subject.MESHAged-
dc.subject.MESHAged, 80 and over-
dc.subject.MESHCarcinoma, Transitional Cell/mortality-
dc.subject.MESHCarcinoma, Transitional Cell/pathology*-
dc.subject.MESHCarcinoma, Transitional Cell/surgery*-
dc.subject.MESHFemale-
dc.subject.MESHHumans-
dc.subject.MESHKidney Neoplasms/mortality-
dc.subject.MESHKidney Neoplasms/pathology*-
dc.subject.MESHKidney Neoplasms/surgery*-
dc.subject.MESHKidney Pelvis*-
dc.subject.MESHLymphatic Metastasis-
dc.subject.MESHMale-
dc.subject.MESHMiddle Aged-
dc.subject.MESHNeoplasm Invasiveness-
dc.subject.MESHNeoplasm Staging-
dc.subject.MESHNephrectomy*/methods-
dc.subject.MESHPrognosis-
dc.subject.MESHSurvival Rate-
dc.subject.MESHUreter/surgery*-
dc.subject.MESHUreteral Neoplasms/mortality-
dc.subject.MESHUreteral Neoplasms/pathology*-
dc.subject.MESHUreteral Neoplasms/surgery*-
dc.subject.MESHVascular Neoplasms/pathology*-
dc.titleLymphovascular invasion and pT stage are prognostic factors in patients treated with radical nephroureterectomy for localized upper urinary tract transitional cell carcinoma-
dc.typeArticle-
dc.contributor.collegeCollege of Medicine (의과대학)-
dc.contributor.departmentDept. of Urology (비뇨기과학)-
dc.contributor.googleauthorDong Suk Kim-
dc.contributor.googleauthorYoung Hoon Lee-
dc.contributor.googleauthorKang Su Cho-
dc.contributor.googleauthorNam Hoon Cho-
dc.contributor.googleauthorByung Ha Chung-
dc.contributor.googleauthorSung Joon Hong-
dc.identifier.doi10.1016/j.urology.2009.07.1350-
dc.admin.authorfalse-
dc.admin.mappingfalse-
dc.contributor.localIdA00403-
dc.contributor.localIdA02969-
dc.contributor.localIdA03607-
dc.contributor.localIdA03801-
dc.contributor.localIdA03812-
dc.contributor.localIdA04402-
dc.relation.journalcodeJ02775-
dc.identifier.eissn1527-9995-
dc.identifier.pmid20018349-
dc.identifier.urlhttp://www.sciencedirect.com/science/article/pii/S0090429509026004-
dc.contributor.alternativeNameKim, Dong Suk-
dc.contributor.alternativeNameLee, Young Hoon-
dc.contributor.alternativeNameChung, Byung Ha-
dc.contributor.alternativeNameCho, Kang Su-
dc.contributor.alternativeNameCho, Nam Hoon-
dc.contributor.alternativeNameHong, Sung Joon-
dc.contributor.affiliatedAuthorKim, Dong Suk-
dc.contributor.affiliatedAuthorLee, Young Hoon-
dc.contributor.affiliatedAuthorChung, Byung Ha-
dc.contributor.affiliatedAuthorCho, Kang Su-
dc.contributor.affiliatedAuthorCho, Nam Hoon-
dc.contributor.affiliatedAuthorHong, Sung Joon-
dc.citation.volume75-
dc.citation.number2-
dc.citation.startPage328-
dc.citation.endPage332-
dc.identifier.bibliographicCitationUROLOGY, Vol.75(2) : 328-332, 2010-
dc.identifier.rimsid37756-
dc.type.rimsART-
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Pathology (병리학교실) > 1. Journal Papers
1. College of Medicine (의과대학) > Dept. of Urology (비뇨의학교실) > 1. Journal Papers

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.